IMPLANT SCIENCES CORP 4
4 · IMPLANT SCIENCES CORP · Filed Mar 10, 2014
Insider Transaction Report
Form 4
IMPLANT SCIENCES CORPOTCBB:IMSC
BOLDUC GLENN D
Chief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2014-03-06+75,000→ 75,000 totalExercise: $0.79Exp: 2024-03-05→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]These options will vest and become exercisable in full upon the later of (i) the addition of the Issuer's QS-B220 product to the Transportation Security Administration (TSA) Qualified Product List for passenger checkpoint screening and (ii) the Issuer's receipt of an initial order for such products under an indefinite delivery/indefinite quantity contract with the TSA.